AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
Log in

LON:DEMGDeltex Medical Group Share Price, Forecast & News

GBX 1.30
-0.10 (-7.14 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
1.20
Now: GBX 1.30
1.40
50-Day Range
1.45
MA: GBX 1.55
1.70
52-Week Range
0.01
Now: GBX 1.30
2.90
Volume1.04 million shs
Average Volume1.22 million shs
Market Capitalization£6.82 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Deltex Medical Group plc manufactures and sells oesophageal doppler monitoring (ODM) systems in the United Kingdom, the United States, Spain, Canada, and internationally. It develops, designs, manufactures, and markets medical devices that generate low frequency ultrasound signal to visualize and measure blood flow in the central circulation. The company offers CardioQ-ODM that allows clinicians to guide fluid and drug administration during surgery and critical care; CardioQ-ODM+, a fluid management and cardiac output monitoring system to measure flow and pressure directly for adults and paediatrics; high definition impedance cardiography, a non-invasive cardiac output and fluid status monitoring system; oesophageal doppler probes; and FORE-SIGHT elite absolute tissue oximetry, which allows clinicians to treat cerebral desaturation events. It also provides high definition impedance cardiography for non-invasive cardiac output and fluid status monitoring; and intubrite video laryngoscopes and laryngoscopes. The company was incorporated in 2000 and is based in Chichester, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1243-774837

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£4.26 million
Cash FlowGBX 0.17 per share
Book ValueGBX 0.50 per share

Profitability

Miscellaneous

Employees56
Market Cap£6.82 million
Next Earnings DateN/A
OptionableNot Optionable

Receive DEMG News and Ratings via Email

Sign-up to receive the latest news and ratings for DEMG and its competitors with MarketBeat's FREE daily newsletter.

Deltex Medical Group (LON:DEMG) Frequently Asked Questions

How has Deltex Medical Group's stock been impacted by COVID-19 (Coronavirus)?

Deltex Medical Group's stock was trading at GBX 1.15 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, DEMG stock has increased by 13.0% and is now trading at GBX 1.30. View which stocks have been most impacted by Coronavirus.

How were Deltex Medical Group's earnings last quarter?

Deltex Medical Group plc (LON:DEMG) posted its quarterly earnings results on Wednesday, May, 9th. The company reported ($0.70) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.60) by $0.10. View Deltex Medical Group's earnings history.

Has Deltex Medical Group been receiving favorable news coverage?

News stories about DEMG stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Deltex Medical Group earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news about Deltex Medical Group.

Who are some of Deltex Medical Group's key competitors?

What other stocks do shareholders of Deltex Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Deltex Medical Group investors own include Indivior (INDV), Nanoco Group (NANO), Ocado Group (OCDO), Tullow Oil (TLW), Actua (ACTA), Bigblu Broadband (BBB), Directa Plus (DCTA), Futura Medical (FUM), Ilika (IKA) and Lakehouse (LAKE).

Who are Deltex Medical Group's key executives?

Deltex Medical Group's management team includes the following people:
  • Mr. Jonathan David Shaw, Fin. Director, Company Sec. & Director (Age 50)
  • Mr. Andrew Jonathan Mears, CEO & Director (Age 50)
  • Dr. Graham Lowe, Chief Operating Officer
  • Ms. Marion Lee, HR Director

What is Deltex Medical Group's stock symbol?

Deltex Medical Group trades on the London Stock Exchange (LON) under the ticker symbol "DEMG."

How do I buy shares of Deltex Medical Group?

Shares of DEMG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Deltex Medical Group's stock price today?

One share of DEMG stock can currently be purchased for approximately GBX 1.30.

How big of a company is Deltex Medical Group?

Deltex Medical Group has a market capitalization of £6.82 million and generates £4.26 million in revenue each year. Deltex Medical Group employs 56 workers across the globe.

What is Deltex Medical Group's official website?

The official website for Deltex Medical Group is www.deltexmedical.com.

How can I contact Deltex Medical Group?

Deltex Medical Group's mailing address is Terminus Road, CHICHESTER, PO19 8TX, United Kingdom. The company can be reached via phone at +44-1243-774837.

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.